1 Min Read
April 6 (Reuters) - Shield Therapeutics PLC:
* CONFIRMS PLANS TO SUBMIT A NEW DRUG APPLICATION FOR FERACCRU® AS SOON AS POSSIBLE
* NEW DRUG APPLICATION (NDA) SUBMISSION MEETING Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.